SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 8,427.30 |
| Enterprise Value ($M) | 8,205.36 |
| Book Value ($M) | 1,986.36 |
| Book Value / Share | 35.47 |
| Price / Book | 4.24 |
| NCAV ($M) | 283.36 |
| NCAV / Share | 5.06 |
| Price / NCAV | 29.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.00 |
| Return on Assets (ROA) | -0.00 |
| Return on Equity (ROE) | -0.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.56 |
| Current Ratio | 6.65 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,158.92 |
| Assets | 2,861.92 |
| Liabilities | 875.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 11.40 | 4.47 | |
| 13G/A | BlackRock, Inc. | 12.70 | 0.00 | |
| 13G/A | Vanguard Group Inc | 9.10 | -2.44 | |
| 13G/A | Eddleman Roy T | 4.85 | 0.00 | |
| 13G/A | BlackRock Inc. | 14.10 | 28.35 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 174,166 | 647,009 | 26.92 | |
| 286,790 | 887,807 | 32.30 | |
| 314,463 | 1,205,171 | 26.09 | |
| 108,353 | 609,508 | 17.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RDUS – Radius Recycling, Inc. | REGN – Regeneron Pharmaceuticals, Inc. |
| REPL – Replimune Group, Inc. | RGNX – REGENXBIO Inc. |
| RIGL – Rigel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io